Management of abnormal uterine bleeding in the current realities

Authors

DOI:

https://doi.org/10.18370/2309-4117.2025.78.8-14

Keywords:

abnormal uterine bleeding, polycystic ovarian syndrome, phytotherapy, quality of life, psycho-emotional state

Abstract

Objective of the study: to optimize approaches to the treatment of abnormal uterine bleeding (AUB) in internally displaced women, considering its impact on patients’ quality of life, mental health, and daily activity.

Materials and methods. The study included 90 women aged 18–55 years diagnosed with AUB. The patients were divided into three groups of 30 people, who received different treatments for 3 months during menstruation and bloody discharge: group I took a herbal hemostatic complex (Foxygen); group II took a hemostatic complex in combination with a preparation of Vitex agnus castus extract Ze440 20 mg (Prefemin); group III (control) took a tranexamic acid 500 mg three times a day. The effectiveness of therapy was assessed using the SF-36 scale for quality of life evaluation, the SAN scale for assessing well-being, activity, and mood, as well as by measuring the duration and volume of blood loss.

Results. After three months of therapy, all groups showed a significant reduction in the duration and intensity of bleeding (p < 0.05). The best results were observed in group II, where the mean duration of bleeding decreased to 5.1 ± 0.7 days, and the menstrual blood loss volume decreased to 61.2 ± 7.4 ml. In group III, these values were 5.0 ± 0.8 days and 57.5 ± 6.1 ml, respectively. Quality of life improvements on the SF-36 scale were most pronounced in group II, particularly in general health perception, social functioning, and mental health. The SAN scale demonstrated significant improvements in well-being and mood, especially in groups II and III.

Conclusions. The combined use of herbal preparations is an effective and safe alternative to standard AUB therapies in women. This therapy not only supports hemostasis but also positively influences the patients’ psycho-emotional state, making it a crucial component of comprehensive AUB management in stressful conditions.

Author Biographies

T.F. Tatarchuk, SI «All-Ukrainian Centre for Motherhood and Childhood of the NAMS of Ukraine»; SSI “Center for Innovative Medical Technologies of the NAS of Ukraine», Kyiv

MD, professor, corresponding member of the NAMS of Ukraine, deputy director for research work, head of the Endocrine Gynecology Department;
chief researcher of the Department of Reproductive Health

N.V. Kosei, SI “All-Ukrainian Center for Maternity and Childhood of the NAMS of Ukraine”, Kyiv

MD, professor, chief researcher, Endocrine Gynecology Department

N.F. Zakharenko, SI «All-Ukrainian Centre for Motherhood and Childhood of the NAMS of Ukraine»; Clinic «Institute of Family Planning», Kyiv

MD, professor, leading researcher, Endocrine Gynecology Department;
head of the scientific board

T.M. Tutchenko, SI “All-Ukrainian Center for Maternity and Childhood of the NAMS of Ukraine”; SI «Center for Innovative Medical Technologies of the NAS of Ukraine», Kyiv

PhD, senior researcher, Endocrine Gynecology Department;
Department of Reproductive Health

O.G. Parkhometnko, SI “All-Ukrainian Center for Maternity and Childhood of the NAMS of Ukraine”, Kyiv

junior researcher, Endocrine Gynecology Department

T.E. Krysenko, SI “All-Ukrainian Center for Maternity and Childhood of the NAMS of Ukraine”, Kyiv

postgraduate student, Endocrine Gynecology Department

References

  1. Munro MG, Critchley HO, Fraser IS, FIGO Menstrual Disorders Working Group. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril. 2011 Jun;95(7):2204–8, 2208.e1-3. DOI: 10.1016/j.fertnstert.2011.03.079.
  2. Deneris A. PALM-COEIN Nomenclature for Abnormal Uterine Bleeding. J Midwifery Womens Health. 2016 May;61(3):376–9. DOI: 10.1111/jmwh.12440.
  3. Sriprasert I, Pakrashi T, Kimble T, Archer DF. Heavy menstrual bleeding diagnosis and medical management. Contracept Reprod Med. 2017 Jul 24;2:20. DOI: 10.1186/s40834-017-0047-4.
  4. Unified clinical protocol for primary, secondary (specialized) and tertiary (highly specialized) medical care «Abnormal uterine bleeding» [Internet]. Verkhovna Rada of Ukraine. 2016. Available from: https://zakon. rada.gov.ua/rada/show/v0353282-16#Text
  5. Weyand AC, Fitzgerald KD, McGrath M, et al. Depression in Female Adolescents with Heavy Menstrual Bleeding. J Pediatr. 2022 Jan;240:171–6. DOI: 10.1016/j.jpeds.2021.09.007.
  6. Committee on Practice Bulletins—Gynecology. Practice bulletin no. 128: diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol. 2012 Jul;120(1):197–206. DOI: 10.1097/AOG.0b013e318262e320.
  7. Attia GM, Alharbi OA, Aljohani RM. The Impact of Irregular Menstruation on Health: A Review of the Literature. Cureus. 2023 Nov 20;15(11):e49146. DOI: 10.7759/cureus.49146.
  8. UNHCR.Global Trends: Forced Displacement in 2022. [Internet]. UNHCR; 2023. Available from: https://www.unhcr.org/global-trends#:~:text=The%20increase%20to%20117.3%20 million,population%2C%20is%20now%20forcibly%20 displaced
  9. Zhou X, Yang X. Association between obesity and oligomenorrhea or irregular menstruation in Chinese women of childbearing age: a cross-sectional study. Gynecological Endocrinology. 2020 Dec;36(12):1101–5. DOI: 10.1080/09513590.2020.1803823
  10. Kitahara Y, Hiraike O, Ishikawa H, et al. National survey of abnormal uterine bleeding according to the FIGO classification in Japan. J. Obstet. Gynaecol. Res. 2023. 49: 321–30. DOI: 10.1111/jog.15464
  11. World Health Organization. Seventy-seventh World Health Assembly, Geneva, 21–30 May 2024. A77/CONF./11. [Internet]. Geneva: WHO; 2024. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA77/A77_ACONF11-en.pdf
  12. IASC guidelines on mental health and psychosocial support in emergency settings. [Internet]. Inter-Agency Standing Committee. 2007. Available from: https://interagencystandingcommittee. org/sites/default/files/migrated/2020-11/IASC%20 Guidelines%20on%20Mental%20Health%20and%20 Psychosocial%20Support%20in%20Emergency%20 Settings%20%28English%29.pdf
  13. Schindler AE. Non-contraceptive benefits of oral hormonal contraceptives. Int J Endocrinol Metab. 2013 Winter;11(1):41–7. DOI: 10.5812/ijem.4158. Epub 2012 Dec 21.
  14. Le Guen M, Schantz C, Régnier-Loilier A, de La Rochebrochard E. Reasons for rejecting hormonal contraception in Western countries: A systematic review. Soc Sci Med. 2021 Sep;284:114247. DOI: 10.1016/j.socscimed.2021.114247.
  15. Medina-Perucha L, López-Jiménez T, Pujolar-Díaz G, et al. Menstrual characteristics and associations with sociodemographic factors and self-rated health in Spain: a cross-sectional study. BMC Women’s Health. 2024 Feb 3;24(1):88. DOI: 10.1186/s12905-023-02840-z
  16. Yu Y, Zhou Z, Wang L, Liu J. Effect of Mirena Intrauterine Device on Endometrial Thickness, Quality of Life Score, and Curative Effect in Patients with Perimenopausal Abnormal Uterine Bleeding. Comput Math Methods Med. 2022 Sep 30;2022:5648918. DOI: 10.1155/2022/5648918.
  17. Csupor D, Lantos T, Hegyi P, et al. Vitex agnus-castus in premenstrual syndrome: A meta-analysis of double-blind randomised controlled trials. Complement Ther Med. 2019 Dec;47:102190. DOI: 10.1016/j.ctim.2019.08.024.
  18. Cerqueira RO, Frey BN, Leclerc E, Brietzke E. Vitex agnus castus for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health. 2017 Dec;20(6):713–719. DOI: 10.1007/s00737-017-0791-0.
  19. Naafe M, Kariman N, Keshavarz Z, et al. Effect of Hydroalcoholic Extracts of Capsella Bursa-Pastoris on Heavy Menstrual Bleeding: A Randomized Clinical Trial. J Altern Complement Med. 2018 Jul;24(7):694–700. DOI: 10.1089/acm.2017.0267.
  20. Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 2016 Oct 4;4:2050312116671725. DOI: 10.1177/2050312116671725.
  21. Handbook of medical and psychological support. Collection of methods: Daily shift [Internet]. 2020. [citation date 03.03.25]. Available from: https://dovidnykmpz.info/wp-content/uploads/2020/04/Zbirnyk-metodyk-dobovyy-nariad.pdf
  22. Damone AL, Joham AE, Loxton D, et al. Depression, anxiety and perceived stress in women with and without PCOS: a community-based study. Psychol Med. 2019 Jul;49(9):1510–20. DOI: 10.1017/S0033291718002076
  23. Dybciak P, Humeniuk E, Raczkiewicz D, et al. Anxiety and Depression in Women with Polycystic Ovary Syndrome. Medicina. 2022 Jul 16;58(7):942. DOI: 10.3390/medicina58070942
  24. Bradley LD, Gueye NA. The medical management of abnormal uterine bleeding in reproductive-aged women. Am J Obstet Gynecol. 2016 Jan;214(1):31–44. DOI: 10.1016/j.ajog.2015.07.044.
  25. Christelle K, Norhayati MN, Jaafar SH. Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use. Cochrane Database Syst Rev. 2022 Aug 26;8(8):CD006034. DOI: 10.1002/14651858.CD006034.pub3.

Published

2025-06-20

How to Cite

Tatarchuk, T., Kosei, N., Zakharenko, N., Tutchenko, T., Parkhometnko, O., & Krysenko, T. (2025). Management of abnormal uterine bleeding in the current realities. REPRODUCTIVE ENDOCRINOLOGY, (78), 8–14. https://doi.org/10.18370/2309-4117.2025.78.8-14

Issue

Section

Gynecology